These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26098216)

  • 1. Mature T cell responses are controlled by microRNA-142.
    Sun Y; Oravecz-Wilson K; Mathewson N; Wang Y; McEachin R; Liu C; Toubai T; Wu J; Rossi C; Braun T; Saunders T; Reddy P
    J Clin Invest; 2015 Jul; 125(7):2825-40. PubMed ID: 26098216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.
    Wu Y; Heinrichs J; Bastian D; Fu J; Nguyen H; Schutt S; Liu Y; Jin J; Liu C; Li QJ; Xia C; Yu XZ
    Blood; 2015 Sep; 126(11):1314-23. PubMed ID: 26138686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
    Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
    Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease.
    Lim JY; Park MJ; Im KI; Kim N; Park HS; Lee SH; Kim EK; Nam YS; Lee ES; Cho ML; Cho SG
    Exp Hematol; 2015 Jan; 43(1):23-31.e1-2. PubMed ID: 25246268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
    Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
    J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease.
    Maeda Y; Tawara I; Teshima T; Liu C; Hashimoto D; Matsuoka K; Tanimoto M; Reddy P
    Exp Hematol; 2007 Feb; 35(2):274-86. PubMed ID: 17258076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis.
    Oertli M; Engler DB; Kohler E; Koch M; Meyer TF; Müller A
    J Immunol; 2011 Oct; 187(7):3578-86. PubMed ID: 21880981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
    Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A
    Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.
    Sun Y; Tawara I; Zhao M; Qin ZS; Toubai T; Mathewson N; Tamaki H; Nieves E; Chinnaiyan AM; Reddy P
    J Clin Invest; 2013 Nov; 123(11):4739-54. PubMed ID: 24216511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
    Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
    Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
    Li Q; Qiu XM; Li QH; Wang XY; Li L; Xu M; Dong M; Xiao YB
    Oncol Rep; 2015 May; 33(5):2354-60. PubMed ID: 25708247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
    Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
    Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease.
    Koenecke C; Krueger A
    Front Immunol; 2018; 9():992. PubMed ID: 29867969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4.
    Sonkoly E; Janson P; Majuri ML; Savinko T; Fyhrquist N; Eidsmo L; Xu N; Meisgen F; Wei T; Bradley M; Stenvang J; Kauppinen S; Alenius H; Lauerma A; Homey B; Winqvist O; Ståhle M; Pivarcsi A
    J Allergy Clin Immunol; 2010 Sep; 126(3):581-9.e1-20. PubMed ID: 20673989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts.
    Li J; Gong J; Li P; Li M; Liu Y; Liang S; Gong J
    Transplantation; 2014 Mar; 97(6):626-35. PubMed ID: 24531847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of T lymphocyte activation by microRNA-21.
    Wang L; He L; Zhang R; Liu X; Ren Y; Liu Z; Zhang X; Cheng W; Hua ZC
    Mol Immunol; 2014 Jun; 59(2):163-71. PubMed ID: 24631982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function.
    Pucella JN; Yen WF; Kim MV; van der Veeken J; Luo CT; Socci ND; Naito Y; Li MO; Iwai N; Chaudhuri J
    J Immunol; 2015 Mar; 194(6):2635-42. PubMed ID: 25672759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.